| Literature DB >> 12822184 |
Michael A Evans1, Daniel C Smith, Justin M Holub, Anthony Argenti, Mafoloe Hoff, Gerard A Dalglish, Donna L Wilson, Brett M Taylor, Joshua D Berkowitz, Bruce S Burnham, Keith Krumpe, John T Gupton, Tanya C Scarlett, Richard W Durham, Iris H Hall.
Abstract
The substituted ethyl-2-phenacyl-3-phenylpyrrole-4-carboxylates were synthesized by a condensation of a beta-chloroenal and an alpha-aminoketone under neutral conditions. They proved to be potent cytotoxic agents against the growth of murine L1210 and P388 leukemias and human HL-60 promyelocytic leukemia, HuT-78 lymphoma, and HeLa-S(3) uterine carcinoma. Selective compounds were active against the growth of Tmolt(3) and Tmolt(4) leukemias and THP-1 acute monocytic leukemia, liver Hepe-2, ovary 1-A9, ileum HCT-8 adenocarcinoma, and osteosarcoma HSO. A mode of action study in HL-60 cells demonstrated that DNA and protein syntheses were inhibited after 60 min at 100 microM. DNA and RNA polymerases, PRPP-amido transferase, dihydrofolate reductase, thymidylate synthase, and TMP kinase activities were interfered with by the agent with reduction of d[NTP] pools. Nonspecific interaction with the bases of DNA and cross-linking of the DNA may play a role in the mode of action of these carboxylates.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12822184 DOI: 10.1002/ardp.200390018
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751